Nasdaq Composite & Eli Lilly and Company
7 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
Nasdaq Composite: The Nasdaq Composite gained, reflecting positive performance in technology and growth stocks, particularly those related to AI.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
International
Nasdaq Composite: The Nasdaq Composite, with its heavy emphasis on tech stocks, led the market lower with substantial slides, indicating the direct impact of the AI stock sell-off.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Jun 03, 2026 · 191 articles
Domestic
Nasdaq Composite: The Nasdaq Composite fell due to weakness in AI-related stocks, suggesting a more cautious sentiment in the technology sector.
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
NEWSDESK
Explore this relationship live
Track how Nasdaq Composite and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard